H A Vaupel - JoVE Visualize

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Onkologie|December 1, 1983

[Vinblastine, 5-fluorouracil and prednisone (VFP) as "second-line" chemotherapy. Contribution to the problem of optimal therapy sequence in metastasizing breast carcinoma]H J Illiger, J Peiss, H A Vaupel, et al.

Klinische Wochenschrift|November 9, 1990

[Primary bilateral, adrenal, highly malignant B-cell lymphoma with lymphoblastic mengiosis]G M Robertz-Vaupel, A G Glasmacher, J Vogel, et al.

MMW, Munchener Medizinische Wochenschrift|February 6, 1981

[The Bonn Cooperative Tumor Aftercare Model. A contribution to the amelioration of tumor patient care in the practitioner's office (author's transl)]H J Illiger, J Hartlapp, M Naubereit, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1985

Intensified induction and consolidation with or without maintenance chemotherapy for acute myeloid leukemia (AML): two multicenter studies of the German AML Cooperative GroupT Büchner, D Urbanitz, W Hiddemann, et al.

Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Onkologie|December 1, 1983

[Vinblastine, 5-fluorouracil and prednisone (VFP) as "second-line" chemotherapy. Contribution to the problem of optimal therapy sequence in metastasizing breast carcinoma]H J Illiger, J Peiss, H A Vaupel, et al.

Klinische Wochenschrift|November 9, 1990

[Primary bilateral, adrenal, highly malignant B-cell lymphoma with lymphoblastic mengiosis]G M Robertz-Vaupel, A G Glasmacher, J Vogel, et al.

MMW, Munchener Medizinische Wochenschrift|February 6, 1981

[The Bonn Cooperative Tumor Aftercare Model. A contribution to the amelioration of tumor patient care in the practitioner's office (author's transl)]H J Illiger, J Hartlapp, M Naubereit, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1985

Intensified induction and consolidation with or without maintenance chemotherapy for acute myeloid leukemia (AML): two multicenter studies of the German AML Cooperative GroupT Büchner, D Urbanitz, W Hiddemann, et al.

Pageof 1